New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

As cancer immunotherapy continues to evolve, the immunosuppressive tumor microenvironment (TME) remains a major barrier to effective treatment. Now ...

Mass General Brigham study tracks how the tumor microenvironment develops during progression, signaling an opportunity for ...

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic ...

Event: Jefferies Global Healthcare Conference Location: London Presentation: Tuesday, November 18, 2025, at 3:00 PM GMT Presenter: Mai-Britt Zocca, PhD, President & CEO Webcast Link: ...

During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.

Detailed price information for Mink Therapeutics Inc (INKT-Q) from The Globe and Mail including charting and trades.

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases, today announced the publication of new ...

From lasers to stem cell therapy, no treatment is being spared for injured Montreal Alouettes starting quarterback Davis ...

Nektar Therapeutics develops novel immunomodulatory drugs targeting autoimmune diseases and oncology. Click here to read why ...